Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission

  • Protocol
  • Intervention



This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of this study will be to evaluate the efficacy of interleukin-2 (IL-2) as maintenance therapy in patients with acute myeloid leukaemia (AML) who have achieved first complete remission (CR).